COMPANY PROFILE

Seismic Therapeutic

Explore full profile

The Machine Learning Immunology Company

Watertown, United StatesFounded 2020Biotech & Life Sciences

Valuation $500M–1B Last recorded · 2023

Headcount <100 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About Seismic Therapeutic

Seismic Therapeutic is a startup that operates in the biotechnology industry, specifically focusing on drug discovery for autoimmune diseases. The company uses machine learning, a type of artificial intelligence that enables computers to learn from data, to accelerate the discovery of biologics drugs. Biologics are medicines made from living organisms, and they are used to treat diseases like rheumatoid arthritis and multiple sclerosis.

Seismic Therapeutic's unique approach combines technology and biology, aiming to bring positive change to the autoimmune landscape. The company's clients are primarily in the healthcare sector, including hospitals, clinics, and other medical institutions that treat patients with autoimmune diseases.

The business model of Seismic Therapeutic revolves around the research, development, and commercialization of biologics drugs. The company generates revenue by developing these drugs and then selling them to healthcare providers. Additionally, the company also participates in scientific meetings and presents its research findings, which can lead to collaborations and partnerships, further contributing to its revenue.

Seismic Therapeutic has been recognized for its promising work in the biotech industry, having been selected as one of the 11 Most Promising Biotech Startups by Endpoints. The company's commitment to inclusivity and collaboration is also noteworthy, as it believes that its impact on drug discovery is directly related to its willingness to embrace these values.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2020
Headquarters: Watertown, United States
Employees: 47
Open positions: 2
Dealroom signal: 65.3/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Drug Development, Core AI, Spinout, Biotech and Pharma, AI Drug Discovery, Techbio, AI Applications, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

Founder mafia, market maps, research and news connected to this company by Dealroom

Funding history

3 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES BOther financing	Dec 2023	$121M	$484M	Bessemer Venture Partners · Polaris Partners · Alexandria Venture Investments · Samsara BioCapital	↗
SERIES AOther financing	Feb 2022	$110M	$440M	Polaris Partners · Timothy A. Springer · Boxer Capital · Samsara BioCapital	↗

Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Seismic Therapeutic website traffic

Latest recorded traffic for Seismic Therapeutic is 6.1K monthly website visits, up 96.8% over the last three months. Seismic Therapeutic's team declined 14.5% over the past year.

Latest monthly visits6.1K 3-month web change+96.8% 1-year team growth-14.5%

Monthly website visitsJan 2021–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

(S)VP Business DevelopmentCambridge, Middlesex County, Massachusetts, 02142, United States · Business Development · Aug 14, 2026

1 distinct opening shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
ELEllogon.aiWorking on personalizing immunotherapy with the power of big and rich data, cutting-edge algorithms, and, of course, a world-class research and development team	Amsterdam, Netherlands	Operational	6	$1.7M	—
SCScailyteDeveloping artificial intelligence technology for the discovery of complex disease patterns from single-cell data	Basel, Switzerland	Operational
PEPepticomAn Artificial Intelligence (AI) company for the discovery of novel molecules in the Pharmaceutical and Agricultural markets	Jerusalem, Israel	Operational
VIVilyaDeveloping a novel class of drugs that precisely target the biology of disease	Seattle, United States	Operational
MAManaAn AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy	Tel Aviv-Yafo, Israel	Operational
MTMETiS TherapeuticsAI-driven platform for drug discovery and delivery	Cambridge, United States	Operational
ATAthos therapeuticsPioneering the Development of Artificial Intelligence-based Precision Therapeutics for Chronic Inflammatory Diseases	Torrance, United States	Operational
BIBioSimulyticsIn-silico drug development for API small molecules ⚛️	Dublin, Ireland	Operational